RCM
RGNX icon

Riverhead Capital Management’s Regenxbio RGNX Stock Holding History

Riverhead Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$93K Buy
2,600
+200
+8% +$8.1K ﹤0.01% 1341
2019
Q2 		$123K Hold
2,400
– – ﹤0.01% 1293
2019
Q1 		$138K Buy
2,400
+100
+4% +$4.95K 0.01% 1246
2018
Q4 		$96K Buy
2,300
+400
+21% +$23.5K ﹤0.01% 1313
2018
Q3 		$143K Buy
1,900
+1,100
+138% +$79.3K 0.01% 1307
2018
Q2 		$57K Buy
+800
New +$38.2K ﹤0.01% 1445

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverhead Capital Management's RGNX Position: Q3 2019 in Review

Riverhead Capital Management increased its Regenxbio (RGNX) stake by 8.3% in Q3 2019, buying an estimated $8.1K and bringing the position to 2,600 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

Riverhead Capital Management first reported a position in RGNX in Q2 2018 and has held it in 6 quarters since. The position peaked at $143K in Q3 2018. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

  • Riverhead Capital Management held 2,600 shares of Regenxbio worth $93K as of Q3 2019.
  • Riverhead Capital Management bought 200 Regenxbio shares in Q3 2019, an estimated $8.1K.
  • Regenxbio made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1341 holding.
  • Riverhead Capital Management first reported a position in Regenxbio in Q2 2018 and has held it in 6 quarters since.
  • Riverhead Capital Management's Regenxbio position peaked at $143K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.